Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
To assess the clinical efficacy of ALC in the treatment of severe hepatic encephalopathy (grade 3 of the West Haven grading scale), we performed a randomised, double blind placebo-controlled study administering ALC to cirrhotic patients, evaluating the effects on ammonia levels and performance in cognitive functions.
Hepatic Encephalopathy (Grade 3 of the West Haven Grading Scale)
Please refer to this study by its ClinicalTrials.gov identifier: NCT01223768
|Catania, Italy, 95126|